11.07.2015 Views

Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...

Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...

Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Screening</strong> and diagnostic testsand, hence, optimise d<strong>et</strong>ection, a radioactive probewhich is compatible with restriction enzyme choiceis recommended (Rousseau <strong>et</strong> <strong>al</strong>, 1992).A simplified profile of the DNA banding patternproduced from a double digest is shown in Figure 4.Norm<strong>al</strong> m<strong>al</strong>es have a single band whereas, infem<strong>al</strong>es, a second band is seen representing them<strong>et</strong>hylated, inactivated X chromosome. A fourbandedpattern is produced by a fem<strong>al</strong>e with aPM, since she will have the mutated and norm<strong>al</strong> Xchromosome in both the inactive and active state.In m<strong>al</strong>es, a m<strong>et</strong>hylated band is seen only <strong>for</strong> an FM.Southern blotting has sever<strong>al</strong> disadvantages inthe screening context. First, it cannot be usedto d<strong>et</strong>ermine accurately the repeat size, which isimportant <strong>for</strong> sm<strong>al</strong>l PMs. Second, there is a longlaboratory turn-round time of up to 10 days, largelybecause of the radioactive d<strong>et</strong>ection of fragments;using a phospho-imaging d<strong>et</strong>ection system (such asthat produced by Molecular Synth<strong>et</strong>ics Ltd) couldreduce turn-round time to 1 day. Third, the test isexpensive at about £50–75 per test.DNA amplification by polymerasechain reactionA rapid and relatively cheap m<strong>et</strong>hod of assessingthe repeat size is to amplify part of the DNA.The most common technique is the polymerasechain reaction (PCR), in which the enzyme DNApolymerase is used to process and copy a specifiedsequence. The PCR product can be d<strong>et</strong>ected byradioactive (Fu <strong>et</strong> <strong>al</strong>, 1991; Pergolizzi <strong>et</strong> <strong>al</strong>, 1992;Erster <strong>et</strong> <strong>al</strong>, 1992) or other means (Brown <strong>et</strong> <strong>al</strong>,1993; El-Aleem <strong>et</strong> <strong>al</strong>, 1995; Nanba <strong>et</strong> <strong>al</strong>, 1995;Haddad <strong>et</strong> <strong>al</strong>, 1996; Wang <strong>et</strong> <strong>al</strong>, 1995a). Thus, them<strong>et</strong>hod works on sm<strong>al</strong>ler quantities of less purifiedstarting materi<strong>al</strong>, either blood or mouthwash(Hagerman <strong>et</strong> <strong>al</strong>, 1994a), than Southern blotting.The turn-round time <strong>for</strong> PCR testing is approximately1 week and, <strong>for</strong> a high throughput, thecost may be reduced to £10 per sample.PCR is most suitable <strong>for</strong> d<strong>et</strong>ecting PMs and largenorm<strong>al</strong> <strong>al</strong>leles as it enables improved size resolutionof sm<strong>al</strong>l repeat sequences (Heitz <strong>et</strong> <strong>al</strong>, 1992;Macpherson <strong>et</strong> <strong>al</strong>, 1992a). Its use is limited <strong>for</strong> thed<strong>et</strong>ection of large FMs, and it is unable to d<strong>et</strong>erminem<strong>et</strong>hylation status. There is a tendency <strong>for</strong>large FMs to fail to amplify. This is less of a problemin m<strong>al</strong>es since absence of an expanded fragmentcan be taken to indicate that an FM may be presentand demonstration of a sm<strong>al</strong>l repeat size is sufficientto exclude an FM. In fem<strong>al</strong>es, however, theabsence of one of the two bands expected afterPCR an<strong>al</strong>ysis is ambiguous. A sm<strong>al</strong>l single band isconsistent with(a) preferenti<strong>al</strong> amplification of the sm<strong>al</strong>ler oftwo <strong>al</strong>leles, one of which might be mutated(Brown <strong>et</strong> <strong>al</strong>, 1993; Erster <strong>et</strong> <strong>al</strong>, 1992; Pergolizzi<strong>et</strong> <strong>al</strong>, 1992)(b) norm<strong>al</strong> <strong>al</strong>leles homozygous <strong>for</strong> size(c) norm<strong>al</strong> <strong>al</strong>leles differing by only one CGGrepeat, which are practic<strong>al</strong>ly indistinguishable.Brown and colleagues (1993) have devised am<strong>et</strong>hodology which avoids selective amplificationof the sm<strong>al</strong>ler <strong>al</strong>lele in h<strong>et</strong>erozygotes enablingthem to be differentiated from homozygotes.However, a single <strong>al</strong>lele on PCR is still notfully in<strong>for</strong>mative.PCR and selectiveSouthern blottingSequenti<strong>al</strong> testing is a reasonable compromiseb<strong>et</strong>ween Southern blotting and PCR. The protocol5.2 kb2.8 kbNorm<strong>al</strong>fem<strong>al</strong>eNorm<strong>al</strong>m<strong>al</strong>ePMfem<strong>al</strong>ePMm<strong>al</strong>eFMfem<strong>al</strong>eFMm<strong>al</strong>eFM m<strong>al</strong>emosaic30FIGURE 4 Example of test results using a double digest

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!